Literature DB >> 28212476

[Cartilage island versus temporalis fascia in high-risk tympanic perforation].

Carmen Lucía Durán-Padilla1, Jaime Martínez-Chávez, Norma Amador-Licona, Texar Alfonso Pereyra-Nobara.   

Abstract

BACKGROUND: The tympanoplasty for high-risk tympanic membrane perforation is a challenge. It is necessary to compare the most useful and feasible surgical technics in our environment for these patients. The objective was to compare the cartilage island tympanoplasty for the treatment of high-risk tympanic membrane perforations versus the use of temporalis fascia.
METHODS: Randomized controlled clinical trial in 69 patients of ten years or older, diagnosed with high-risk tympanic membrane perforation in a third level hospital. The MERI index was determined and an initial audiometry was obtained. 7, 30 and 60 days after the tympanoplasty the tympanic graft integrity was evaluated. The audiometry was only repeated at 60 days.
RESULTS: 69 patients were included, 33 received cartilage island (group 1) and 36 temporalis fascia (group 2). 93.9% was the success rate for group 1 at 30 and 60 days and 83.3% for group 2 (p = 0.17). Hearing improvement was neither different between groups (33.1 vs. 33.6 dB; p = 0.88), for group 1 and 2, respectively.
CONCLUSION: No difference in morphological and audiological outcomes using cartilage island tympanoplasty or temporalis fascia for the treatment of high-risk tympanic membrane perforation was found.

Entities:  

Keywords:  Cartilage; Fascia; Tympanic membrane perforation; Tympanoplasty

Mesh:

Year:  2017        PMID: 28212476

Source DB:  PubMed          Journal:  Rev Med Inst Mex Seguro Soc        ISSN: 0443-5117


  1 in total

1.  Randomized Clinical Trial Comparing Bucket Handle and Cartilage Tympanoplasty Techniques for the Reconstruction of Subtotal or Anterior Tympanic Membrane Perforation.

Authors:  Alimohamad Asghari; Mohammad Mohseni; Ahmad Daneshi; Yasser Nasoori; Sara Rostami; Maryam Balali
Journal:  Int J Otolaryngol       Date:  2018-05-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.